Skip to main content
Category

News Archive

D7d9194b 9d8c 4c69 a40d a9eb2517d4b2 pdf

Chancellor’s Message: VISION 2030 — From Excellence to Preeminence

By News Archive

D7d9194b 9d8c 4c69 a40d a9eb2517d4b2 pdfVISION 2030: From Excellence to Preeminence

This summer, the University System of Maryland unveiled a new 10-year strategic plan—Vision 2030: From Excellence to Preeminence. The plan reflects 18 months of in-depth analysis. It coalesces intense discussions among dozens of groups of people with a stake in Maryland’s public universities—people with different opinions on higher education’s main objectives and different ideas on how to achieve them.

But one theme emerged across all groups: That students must serve as our starting point. They must set our agenda. They must center our work.

Click here to view the PDF

Horizon Full Color RGB Registered

Q32 Bio and Horizon Therapeutics Announce Collaboration in Autoimmune Diseases

By News Archive

Horizon Full Color RGB RegisteredWALTHAM, Mass. and DUBLIN, Aug. 15, 2022 /PRNewswire/ — Q32 Bio, a clinical stage biotechnology company developing biologic therapeutics to restore immune homeostasis, and Horizon Therapeutics plc (Nasdaq: HZNP), today announced that they have entered into a collaboration and option agreement to develop ADX-914 for the treatment of autoimmune diseases.

ADX-914 is a fully human anti-IL-7Rα antibody that re-regulates adaptive immune function by blocking signaling mediated by both IL-7 and TSLP. Q32 has recently completed a biomarker-enabled Phase 1 study characterizing pharmacokinetics, pharmacodynamics and safety of ADX-914 that demonstrated pharmacological effect on T cells in healthy volunteers. Q32 expects to initiate a Phase 2 trial in atopic dermatitis later this year and is planning to initiate a Phase 2 trial in a second autoimmune disease next year.

Read More

Alexandria Real Estate Equities and the Transformation of Life Science Real Estate | Nareit

By News Archive

ALilly Institute for Genetic Medicine, 15 Necco Street, Seaport Innovation District, Greater Boston. Photo courtesy Alexandria Real Estate Equities, Inc.
quarter century after it began life as a garage start-up, Alexandria Real Estate Equities, Inc.’s (NYSE: ARE) decision to focus on the niche segment of life science real estate looks sounder than ever as demand for sophisticated lab space across major U.S. markets sits at an all-time high.

Pasadena, California-based Alexandria is the only publicly traded, pure-play office/laboratory REIT. The company, led by founder and Executive Chairman Joel Marcus, focuses exclusively on highly specialized lab space used for research and development in the booming life science industry.

Image: Lilly Institute for Genetic Medicine, 15 Necco Street, Seaport Innovation District, Greater Boston. Photo courtesy Alexandria Real Estate Equities, Inc.

Read More
Albin O. Kuhn Library (Marlayna Demond '11/UMBC)

NSF Awards $10M To UMBC To Expand Successful Initiative Developing Underrepresented Postdocs In STEM – UMBC: University Of Maryland, Baltimore County

By News Archive

Albin O. Kuhn Library (Marlayna Demond '11/UMBC)UMBC will expand its work boosting diversity in academia from Maryland to the national level through a new NSF INCLUDES Alliance: Re-Imagining STEM Equity Utilizing Postdoc Pathways (RISE UPP). The RISE UPP Alliance, anticipated to officially launch in fall 2022, is modeled after the AGEP PROMISE Academy, a high-impact initiative co-led by UMBC that supports faculty diversification in the biomedical sciences across University System of Maryland (USM) institutions.

Image: Albin O. Kuhn Library (Marlayna Demond ’11/UMBC)

Read More
1660230029759

Ellume welcomes Congressman David Trone, Senator Ben Cardin, Senator Chris Van Hollen and National Institute of Standards and Technology (NIST) Manufacturing Extension Partnership Director Laurie Locascio

By News Archive

I1660230029759t was a pleasure to welcome Congressman David Trone, Senator Ben Cardin, Senator Chris Van Hollen and National Institute of Standards and Technology (NIST) Manufacturing Extension Partnership Director Laurie Locascio to our new facility in Frederick this week and to see Ellume’s #manufacturing capabilities first-hand.

Ellume’s Frederick facility provides a sustainable U.S. domestic industrial base for #diagnostics production and stands ready to respond to any future surge in #COVID19 demand, while accelerating #innovation to develop solutions for future public health needs. A multimillion-dollar automation program is underway to further enhance the production capability of the facility.

 

Read More
The three busy female founders of innovative life science startups CarrTech, NasaClip and PerSoN Clinic took time to share what TEDCO’s Builder Fund and other TEDCO resources have meant to their companies.

DC Inno – How 3 women-led life sciences startups thrive with TEDCO

By News Archive

The three busy female founders of innovative life science startups CarrTech, NasaClip and PerSoN Clinic took time to share what TEDCO’s Builder Fund and other TEDCO resources have meant to their companies.Maryland is home to a number of STEM entrepreneurs with quality projects and the skills to succeed. What entrepreneurs often lack are the right connections and access to funding, which is especially true for women-led life sciences start-ups.

“In 2021, women founders raised just 2% of venture capital money and only 23% of biotech CEOs are women said Margia Argüello, formerly with the Maryland Department of Commerce’s Office of Life Sciences.

Image: The three busy female founders of innovative life science startups CarrTech, NasaClip and PerSoN Clinic took time to share what TEDCO’s Builder Fund and other TEDCO resources have meant to their companies.

Read More
autm logo

CHIPS Act Authorizes Unprecedented Support for Tech Transfer

By News Archive

autm logoThe arc of the technology transfer profession can be tied to the Bayh-Dole Act of 1980 in the United States and similar enabling legislation from across the globe. This week  a new transformational law was passed – the CHIPS and Science Act – supporting U.S. semiconductor production and catalyzing research and development in many key technology areas and in new innovation regions of the country. Most importantly, this new law has a key provision titled “Planning and Capacity Building Awards” (Sec. 10391), which authorizes an unprecedented $3.1 billion to support technology transfer capacity building for research institutions.

 

Read More
Ellume COVID test plant in Frederick starting to add automation to manufacturing Coronavirus fredericknewspost com

Ellume COVID test plant in Frederick starting to add automation to manufacturing | Coronavirus | fredericknewspost.com

By News Archive

Ellume COVID test plant in Frederick starting to add automation to manufacturing Coronavirus fredericknewspost comFive months after the Australian-based biopharmaceutical company Ellume opened its first U.S. location in Frederick, the facility is scaling up its production of at-home COVID-19 tests by starting to automate the manufacturing process.

U.S. Rep. David Trone and U.S. Sens. Chris Van Hollen and Ben Cardin visited the sprawling campus along Executive Way on Tuesday afternoon for a tour of the company’s production capabilities and a town hall meeting with its employees.

Image: https://www.fredericknewspost.com – Staff photo by Ric Dugan

Read More
Bf539918 8c8f 454e a1ab 35d98668e1bc pdf

Alexandria – 940 CLOPPER ROAD – GAITHERSBURG, MARYLAND – AVAILABLE 1Q23 – 8,867 RSF OF LABORATORY/OFFICE SPACE

By News Archive

Bf539918 8c8f 454e a1ab 35d98668e1bc pdfTENANT AMENITIES

• 8,867 RSF lab/office suite available 1Q23

• Dedicated suite entry

• Energy efficient HVAC

• Loading dock

• Ample parking

• Complimentary access to the Alexandria FitLab

fitness center (located at 910 Clopper Road)

• On-site asset management

• Proximate to major amenities, including

restaurants, retail, lodging, and banking

Click here for more information.

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.